FDA clears SMV’s coincidence detection
Nuclear medicine vendor SMV America has received 510(k) clearance from the Food and Drug Administration for its Volumetric Coincidence Reconstruction (VCR) technique for its Vision FX-80 gamma camera. SMV, of Twinsburg, OH, joins ADAC Laboratories and
Nuclear medicine vendor SMV America has received 510(k) clearance from the Food and Drug Administration for its Volumetric Coincidence Reconstruction (VCR) technique for its Vision FX-80 gamma camera. SMV, of Twinsburg, OH, joins ADAC Laboratories and Picker International in the group of vendors that have 510(k) clearance for a coincidence-detection technique.
In other SMV America news, the company reported record growth in both orders and product sales for the fourth quarter of 1996, although as a private company it did not release specific dollar figures. The company said that camera and computer orders were up 189%, and shipment revenues increased 64% compared with the same period the year before. For the year, SMV said that product revenues grew by 30% and orders doubled.
SMV America ended the year with a 15.5% market share and a large backlog, the company said, while SMV International, its sister company, saw its market share in Europe expand to 25%.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
